Waist to height ratio is an independent predictor for the incidence of chronic kidney disease

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Odagiri, Keiichi ^a   Mizuta, Isagi ^b   Yamamoto, Makoto ^b   Miyazaki, Yosuke ^c   Watanabe, Hiroshi ^a   Uehara, Akihiko ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yamaha Health Care Center   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEINURIA; WAIST TO HEIGHT RATIO; ADOLESCENT; COHORT ANALYSIS; COMPLICATION; JAPAN; LONGITUDINAL STUDY; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; URINE; YOUNG ADULT;

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; WAIST-HEIGHT RATIO; YOUNG ADULT;

EID: 84895744841     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088873     Document Type: Article

References (35)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
2. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, et al. (2006) Screening strategies for chronic kidney disease in the general population: followup of cross sectional health survey. BMJ 333: 1047.
3. Hooi LS, Ong LM, Ahmad G, Bavanandan S, Ahmad NA, et al. (2013) A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int 84: 1034-1040.
4. Kearns B, Gallagher H, de Lusignan S (2013) Predicting the prevalence of chronic kidney disease in the English population: a cross-sectional study. BMC Nephrol 14: 49-59.
5. Zhang L, Wang F, Wang L, Wang W, Liu B, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379: 815-822.
6. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, et al. (2009) Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 13: 621-630.
7. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047. (Pubitemid 350074801)
8. Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, et al. (2010) Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant 25: 2557-2564.
9. Grams ME, Juraschek SP, Selvin E, Foster MC, Inker LA, et al. (2013) Trends in the Prevalence of Reduced GFR in the United States: A Comparison of Creatinine- and Cystatin C-Based Estimates. Am J Kidney Dis. 62: 253-260.
10. Brosius FC 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, et al. (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 114: 1083-1087. (Pubitemid 44358886)
11. Heerspink HL, de Zeeuw D (2013) Novel drugs and intervention strategies for the treatment of chronic kidney disease. Br J Clin Pharmacol 76: 536-550.
12. Govindarajan G, Whaley-Connell A, Mugo M, Stump C, Sowers JR (2005) The cardiometabolic syndrome as a cardiovascular risk factor. Am J Med Sci 330: 311-318. (Pubitemid 41831902)
13. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, et al. (2006) Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) 14: 336-341. (Pubitemid 46214766)
14. Manolopoulos KN, Karpe F, Frayn KN (2010) Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34: 949-959.
15. Liu J, Fox CS, Hickson D, Bidulescu A, Carr JJ, et al. (2011) Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study. Arterioscler Thromb Vasc Biol 31: 2715-2722.
16. Katzmarzyk PT, Heymsfield SB, Bouchard C (2013) Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. Am J Clin Nutr 97: 480-486.
17. Rothney MP, Catapano AL, Xia J, Wacker WK, Tidone C, et al. (2013) Abdominal visceral fat measurement using dual-energy X-ray: Association with cardiometabolic risk factors. Obesity (Silver Spring) 21: 1798-1802.
18. Hsieh SD, Yoshinaga H, Muto T (2003) Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 27: 610-616. (Pubitemid 36561019)
19. Ashwell M, Gunn P, Gibson S (2012) Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 13: 275-286.
20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992.
21. Chiba Y, Saitoh S, Takagi S, Ohnishi H, Katoh N, et al. (2007) Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study. Hypertens Res 30: 229-236. (Pubitemid 46605447)
22. Liu Y, Tong G, Tong W, Lu L, Qin X (2011) Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects? BMC Public Health 11: 11-35.
23. Sanches FM, Avesani CM, Kamimura MA, Lemos MM, Axelsson J, et al. (2008) Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 52: 66-73. (Pubitemid 351853257)
24. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K (2006) Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 69: 369-374. (Pubitemid 43323089)
25. Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140. (Pubitemid 41716445)
26. Verani RR (1992) Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 20: 629-634.
27. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS (1974) The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 81: 440-447.
28. Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, et al. (2006) Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 147: 44-50. (Pubitemid 43004261)
29. Wisse BE (2004) The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15: 2792-2800.
30. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415.
31. Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278.
32. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40: 1286-1292. (Pubitemid 27469668)
33. Lin CH, Chou CY, Lin CC, Huang CC, Liu CS, et al. (2007) Waist-to-height ratio is the best index of obesity in association with chronic kidney disease. Nutrition 23: 788-793. (Pubitemid 47532397)
34. Zamanzad B (2009) Accuracy of dipstick urinalysis as a screening method for detection of glucose, protein, nitrites and blood. East Mediterr Health J 15: 1323-1328.
35. Tseng CH (2005) Waist-to-height ratio is independently and better associated with urinary albumin excretion rate than waist circumference or waist-to-hip ratio in chinese adult type 2 diabetic women but not men. Diabetes Care 28: 2249-2251. (Pubitemid 41242479)